Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical IndustrySpringer Science & Business Media, 2008 M02 19 - 186 páginas Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia. |
Contenido
Key to Success in the Pharmaceutical Industry 1 The Productivity Paradox 1 The Blockbuster Imperative 4 High Risks in Drug Development 10 Strat... | 19 |
How to Find | 33 |
How to Organize | 50 |
Accessing Earlystage Innovation 78 Inlicensing Enhancing the Innovation Pipeline 81 Codevelopment Mutually Benefiting from Joint Resources 83 ... | 123 |
Index 173 Glossary | 179 |
Otras ediciones - Ver todas
Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the ... Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitz Sin vista previa disponible - 2010 |
Términos y frases comunes
able activities addition agreements alliances allows already application approach approval areas Bayer become billion biotechnology blockbuster Board candidates centers chemical China clinical collaboration compared competition complex compound considered costs countries deal decision discovery disease drug early effective established evaluation example expected external firms function future genes genomics global growth human important improve in-licensing increased innovation integrated International investment knowledge launch lead licensing major manufacturing medicines ment needs Novartis Oncology opportunity organizations out-licensing outsourcing overall patent percent pharma pharmaceutical companies pharmaceutical industry pharmaceutical R&D phase pipeline potential Project Management requires respective Reuters risks Roche scientific screening share significant Source stages strategy structure substance success Switzerland target technologies testing therapeutic therapy tion trials units usually worldwide
Pasajes populares
Página 169 - Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981-2002.
Referencias a este libro
Der Patentauslauf von Pharmazeutika als Herausforderung beim Management des ... Antje-Christina Raasch Sin vista previa disponible - 2006 |
Globalization [2 Volumes]: Encyclopedia of Trade, Labor, and Politics Ashish Vaidya Sin vista previa disponible - 2006 |